Empyema Treated With tPA & DNAse

Summary

The objective of this study is to scientifically evaluate a new substrate for fibrinolysis compared to our standard tPA. The hypothesis, driven by a recent prospective trial, is that tPA may benefit from the addition of DNAse. The primary outcome variable between the two techniques will be length of hospitalization after initiation of treatment.

Timeline

Start

2016-01

Primary completion

2016-01

Completion

2016-01

Outcome

Outcome not reported

Stopped (Business): “funding difficulty”

Drugs

Indications